Lacer Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for LACER PHARMA
LACER PHARMA has two approved drugs.
There is one US patent protecting LACER PHARMA drugs.
Drugs and US Patents for Lacer Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lacer Pharma | ULTRAVATE | halobetasol propionate | LOTION;TOPICAL | 208183-001 | Nov 6, 2015 | RX | Yes | Yes | 8,962,028 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Lacer Pharma | ERTACZO | sertaconazole nitrate | CREAM;TOPICAL | 021385-001 | Dec 10, 2003 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Lacer Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Lacer Pharma | ERTACZO | sertaconazole nitrate | CREAM;TOPICAL | 021385-001 | Dec 10, 2003 | 5,135,943 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Lacer Pharma Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 2919753 | ⤷ Start Trial |
| Eurasian Patent Organization | 029494 | ⤷ Start Trial |
| Mexico | 371362 | ⤷ Start Trial |
| Japan | 6385938 | ⤷ Start Trial |
| Canada | 2888853 | ⤷ Start Trial |
| India | 4160DEN2015 | ⤷ Start Trial |
| Brazil | 112015008951 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

